Buscar
Mostrando ítems 1-10 de 205
Development of an experimental model of liver cirrhosis in rabbits
(Blackwell Science AsiaCarltonAustralia, 2000)
Cirrhosis regression after SVR with indirect methods of fibrosis analysis: How far is it real?
(2021-01-01)
Hepatitis C virus has infected over 71 million people worldwide, and it is the main cause of cirrhosis in the western world. Currently, the treatment involves direct-acting antiviral agents (DAAs) and its main goal is to ...
Thalidomide and its analogs: a potential immunomodulatory alternative for treating liver diseases and cirrhosis
(2011)
Thalidomide is currently used for treating erythema nodosum leprosum, multiple myeloma, angiogenesis, rheumatoid arthritis, graft-versus-host disease, among others. Thalidomide effects are related to its capacity to inhibit ...
Oxidative Stress Modulation by Rosmarinus offi cinalis in CCl4-induced Liver Cirrhosis
(Wiley InterScience, 2009-10)
Rosmarinus offi cinalis (Lamiaceae) possesses antioxidant activity and hepatoprotective effects, and so may
provide a possible therapeutic alternative for chronic liver disease. The effect produced by a methanolic extract
of ...
Inflammation response and liver stiffness: predictive model of regression of hepatic stiffness after sustained virological response in cirrhotics patients with chronic hepatitis C
(2021-01-01)
Cirrhotic patients with chronic hepatitis C should be monitored for the evaluation of liver function and screening of hepatocellular carcinoma even after sustained virological response (SVR). The stage of inflammatory ...
Low doses of insulin-like growth factor-I improve nitrogen retention and food efficiency in rats with early cirrhosis
(Munksgaard Int Publ LtdCopenhagenDinamarca, 1997)